• Gentamycin Sulfate in Resistance Research

  2026-10-06

  A translational perspective on Gentamycin Sulfate as a mechanistic probe for bacterial protein synthesis research, ribosome function analysis, and the interpretation of resistance findings in Gram-negative pathogens.

• Neuroligin 1, Striatal D2-MSNs, and Repetitive Behavior

  2026-10-06

  A study in Advanced Science links Neuroligin 1 loss in dorsal-striatal D2 receptor-expressing medium spiny neurons to excessive self-grooming and digging in mice. Its combination of cell-type-specific behavioral analysis, neuronal activity measurements, single-nucleus RNA sequencing, and protein validation identifies PKC overactivation as a candidate molecular contributor while leaving important questions about isoform specificity and relevance to human autism.

• Five Questions About ATP Luminescence in Ferroptosis

  2026-10-05

  A source-grounded guide to what ATP-based luciferase luminescence measures, how it relates to ferroptosis research, and where evidence, interpretation, and applicability remain limited.

• Biotin-XX Tyramide Reagent for Surface Biology

  2026-10-05

  Biotin-XX Tyramide Reagent, also known as biotin-LC-LC-tyramide, offers a membrane-impermeant perspective on low-abundance surface molecules. This article explains how its chemistry can help interpret activity-dependent synaptic biology without confusing surface localization with total protein abundance.

• Cy5 Amine (Non-Sulfonated): Product Overview

  2026-10-04

  Cy5 amine (non-sulfonated), SKU A8143, is a supplier-described primary-amine cyanine dye for conceptual fluorescent biomolecule-labeling applications. No matched paper evidence is available for independent performance assessment.

• Angiotensin I/II (1-5): Product Overview

  2026-10-03

  APExBIO lists Angiotensin I/II (1-5) as an Asp-Arg-Val-Tyr-Ile peptide fragment for conceptual renin-angiotensin system research. No matched paper evidence was supplied, so biological performance and research outcomes are not independently established here.

• CLCC1 and Herpesvirus Nuclear Egress Fusion

  2026-10-02

  This preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion step of herpesvirus nuclear egress. A whole-genome CRISPR screen with HSV-1, combined with cellular and evolutionary analyses, links CLCC1 loss to perinuclear capsid accumulation, reduced viral production, and defective nuclear pore insertion.

• HRP Goat Anti-Mouse IgG (H+L) Antibody

  2026-10-01

  HRP Goat Anti-Mouse IgG (H+L) Antibody K1221 provides an HRP-labeled secondary reagent for detecting mouse-derived primary antibodies in Western blotting, ELISA, IHC, and ICC. It should be selected when the primary antibody is from mouse and a validated HRP detection system is available; it is not a substitute for a primary antibody or a fluorescence-only secondary reagent.

• Cefiderocol in Resistant P. aeruginosa and Acinetobacter

  2026-10-01

  This European multicenter study shows that cefiderocol retained high in vitro activity against Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and several newer β-lactam/β-lactamase inhibitor combinations. Its integrated susceptibility and genomic analysis clarifies how cefiderocol resistance differs from resistance to other agents and supports parallel susceptibility testing in resistance-focused research.

• Angiotensin I/II (1-5) RAS Workflow Guide

  2026-09-30

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving vascular, renal, blood pressure, and aldosterone-related workflows. It should not be treated as a validated substitute for intact angiotensin peptides or used in unrelated signaling assays without assay-specific qualification.

• PTC124 (Ataluren) in Lowe Syndrome iPSC Assays

  2026-09-30

  PTC124 (Ataluren) can serve as an exploratory pharmacology arm in patient-derived Lowe syndrome models when an OCRL nonsense variant is biologically suitable for readthrough testing. This workflow places compound exposure beside CRISPR correction and OCRL gene augmentation, helping researchers distinguish reversible cellular rescue from durable genetic repair.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-09-29

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation and aldosterone release. It is best suited to cardiovascular and renal workflows and should not be generalized to unrelated peptide-signaling studies without additional validation.

• Angiotensin I/II (1-5): Practical RAS Guide

  2026-09-29

  Angiotensin I/II (1-5), SKU A1047, provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation and aldosterone signaling. It should be limited to cardiovascular and renal workflows, with solvent compatibility and storage verified before use, and should not be treated as a general-purpose peptide for unrelated signaling studies.

• Geneticin, G-418 Sulfate: Reliable Cell Selection

  2026-09-28

  A practical, scenario-based guide to using Geneticin, G-418 Sulfate for cell selection, viability interpretation, and antiviral studies. It explains how SKU A2513 supports reproducible workflows through defined solubility, storage, purity, and concentration guidance.

• Network Medicine Identifies Apigenin for Alzheimer’s

  2026-09-28

  A 2025 study combined network-proximity screening with cell-based experiments to prioritize flavonoids for Alzheimer’s disease research, identifying apigenin as the strongest candidate among four compounds tested. Its findings connect neuroprotection with reduced apoptosis, mitochondrial preservation, and modulation of AKT/NF-κB signaling and microglial inflammatory state, while remaining preclinical.

8128 records 1/542 page Next 12345 下5页 Last page